Board of Directors
Mr Richard Davis
Independent Chairman
Mr. Richard Davis joined the Group in June 2014. Up until recently, Richard served as a non-executive director of ASX listed companies InvoCare Limited (Chairman) and Australian Vintage Limited (Chairman) having resigned from these directorships in 2023 and 2024 respectively. Richard worked for InvoCare for 20 years until 2008.
For the majority of that time he held the position of CEO and managed the growth of that business through a number of ownership changes and over 20 acquisitions, including offshore in Singapore. Prior to InvoCare Limited, Richard worked as an accounting partner of Bird Cameron.
Ms Zita Peach
Independent
Non-executive Director
Ms Zita Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries, and has worked for major industry players such as CSL Limited, Fresenius Kabi and Merck Sharp & Dohme, the Australian subsidiary of Merck Inc.
Zita was Chair of Pacific Smiles Group Limited (ASX listed) and a Non-Executive Director until 28 August 2024. Zita is currently a Non-Executive Director of three private equity owned companies, Icon Group Pty Ltd, VetPartners Pty Ltd and Nucleus Network Pty Ltd. Zita is also the Chair of the Olivia Newton John Cancer Research Institute. Zita is a Fellow of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute.
Mr Neil Broekhuizen
Independent
Non-executive Director
Mr. Neil Broekhuizen is the Joint Chief Executive Officer of Ironbridge.
Neil has over 30 years’ experience in the finance industry including 28 years in private equity with Investcorp and Bridgepoint in Europe and Ironbridge in Australia. He has sat on the Ironbridge Investment Committee since inception.
Ms Catherine West
Independent
Non-executive Director
Ms Catherine West was appointed Non-Executive Director to Monash IVF Group on 8 September 2020. She is an experienced ASX listed non-executive director and has over 25 years of legal, business affairs and strategy experience in customer focused businesses in the media, entertainment, telecommunications and medical sectors in Australia, the United Kingdom and Europe.
Catherine is Chair of ASX listed Nine Entertainment and a NonExecutive Director of Peter Warren Automotive Group. In addition, she is Chair of the National Institute of Dramatic Art (NIDA), a Director of the NIDA Foundation and Chair of the Board of Governors of Wenona School. Catherine was also on the Board of ASX listed Endeavour Group until April 2021, and until recently, a Director of the Sydney Breast Cancer Foundation Limited until her resignation on 30th June 2024. She is a Graduate Member of the Australian Institute of Company Directors.
Dr Richard Henshaw
Executive Director
Dr Richard Henshaw MD FRANZCOG FRCOG has practiced in the field of reproductive medicine since 1995. Richard works as a Fertility Specialist for the Group.
Richard has served on many national bodies, including RANZCOG Council, the IVF Medical Directors Group of Australia and New Zealand, and the Reproductive Technology Accreditation Committee.
Ms Catherine Aston
Independent
Non-Executive Director
Ms. Catherine Aston is an experienced Non-Executive Director / Chair of listed and unlisted entities covering technology, financial services, marketing services, health and government sectors across Australia and Asia. Catherine has a broad commercial background with executive roles in finance, marketing and strategy, including as CFO for Telstra International and Chief Executive Officer of a mobiles joint venture in Sri Lanka. Catherine is currently a NonExecutive Director of Macquarie Investment Management Ltd (Chair of the Audit, Risk and Compliance committee), IVE Group Ltd (Chair of the Audit and Risk Committee) and IMB Bank Ltd (Chair). Catherine’s advisory roles have included work with the NSW State Government and serving as an advisory board member of Avanseus Pty Ltd, a Singapore based AI business. Catherine is a Graduate of the Australian Institute of Company Directors and a Senior Fellow of the Financial Services Institute of Australasia (FINSIA).
Mr Michael Knaap
Managing Director and CEO
Mr Michael Knaap was appointed to the role of Chief Executive Officer and Managing Director for Monash IVF Group on 15 April 2019. Following his tenure as Monash IVF Group’s Chief Financial Officer and Company Secretary since August 2015, Michael was appointed to Interim Chief Executive Officer in October 2018.
Michael has 30 years’ experience in executive positions with a strong financial, operational, strategic and leadership background in Healthcare and FMCG industries. Prior to joining MVF Group, Michael was with Patties Foods Limited where he held a number of executive positions over six years, including the role of Chief Financial Officer and Company Secretary.
Michael is a Graduate of the Australian Institute of Company Directors.
Mr Richard Davis
Independent Chairman
Mr. Richard Davis joined the Group in June 2014. Up until recently, Richard served as a non-executive director of ASX listed companies InvoCare Limited (Chairman) and Australian Vintage Limited (Chairman) having resigned from these directorships in 2023 and 2024 respectively. Richard worked for InvoCare for 20 years until 2008.
For the majority of that time he held the position of CEO and managed the growth of that business through a number of ownership changes and over 20 acquisitions, including offshore in Singapore. Prior to InvoCare Limited, Richard worked as an accounting partner of Bird Cameron.
Ms Zita Peach
Independent
Non-executive Director
Ms Zita Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries, and has worked for major industry players such as CSL Limited, Fresenius Kabi and Merck Sharp & Dohme, the Australian subsidiary of Merck Inc.
Zita was Chair of Pacific Smiles Group Limited (ASX listed) and a Non-Executive Director until 28 August 2024. Zita is currently a Non-Executive Director of three private equity owned companies, Icon Group Pty Ltd, VetPartners Pty Ltd and Nucleus Network Pty Ltd. Zita is also the Chair of the Olivia Newton John Cancer Research Institute. Zita is a Fellow of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute.
Mr Neil Broekhuizen
Independent
Non-executive Director
Mr. Neil Broekhuizen is the Joint Chief Executive Officer of Ironbridge.
Neil has over 30 years' experience in the finance industry including 28 years in private equity with Investcorp and Bridgepoint in Europe and Ironbridge in Australia. He has sat on the Ironbridge Investment Committee since inception.
Ms Catherine West
Independent
Non-executive Director
Ms Catherine West was appointed Non-Executive Director to Monash IVF Group on 8 September 2020. She is an experienced ASX listed non-executive director and has over 25 years of legal, business affairs and strategy experience in customer focused businesses in the media, entertainment, telecommunications and medical sectors in Australia, the United Kingdom and Europe.
Catherine is Chair of ASX listed Nine Entertainment and a NonExecutive Director of Peter Warren Automotive Group. In addition, she is Chair of the National Institute of Dramatic Art (NIDA), a Director of the NIDA Foundation and Chair of the Board of Governors of Wenona School. Catherine was also on the Board of ASX listed Endeavour Group until April 2021, and until recently, a Director of the Sydney Breast Cancer Foundation Limited until her resignation on 30th June 2024. She is a Graduate Member of the Australian Institute of Company Directors.
Dr Richard Henshaw
Executive Director
Dr Richard Henshaw MD FRANZCOG FRCOG has practiced in the field of reproductive medicine since 1995. Richard works as a Fertility Specialist for the Group.
Richard has served on many national bodies, including RANZCOG Council, the IVF Medical Directors Group of Australia and New Zealand, and the Reproductive Technology Accreditation Committee.
Ms Catherine Aston
Independent
Non-Executive Director
Ms. Catherine Aston is an experienced Non-Executive Director / Chair of listed and unlisted entities covering technology, financial services, marketing services, health and government sectors across Australia and Asia. Catherine has a broad commercial background with executive roles in finance, marketing and strategy, including as CFO for Telstra International and Chief Executive Officer of a mobiles joint venture in Sri Lanka. Catherine is currently a NonExecutive Director of Macquarie Investment Management Ltd (Chair of the Audit, Risk and Compliance committee), IVE Group Ltd (Chair of the Audit and Risk Committee) and IMB Bank Ltd (Chair). Catherine's advisory roles have included work with the NSW State Government and serving as an advisory board member of Avanseus Pty Ltd, a Singapore based AI business. Catherine is a Graduate of the Australian Institute of Company Directors and a Senior Fellow of the Financial Services Institute of Australasia (FINSIA).
Mr Michael Knaap
Managing Director and CEO
Mr Michael Knaap was appointed to the role of Chief Executive Officer and Managing Director for Monash IVF Group on 15 April 2019. Following his tenure as Monash IVF Group’s Chief Financial Officer and Company Secretary since August 2015, Michael was appointed to Interim Chief Executive Officer in October 2018.
Michael has 30 years' experience in executive positions with a strong financial, operational, strategic and leadership background in Healthcare and FMCG industries. Prior to joining MVF Group, Michael was with Patties Foods Limited where he held a number of executive positions over six years, including the role of Chief Financial Officer and Company Secretary.
Michael is a Graduate of the Australian Institute of Company Directors.
Management Team
Fiona Allen
Chief Marketing Officer
Sarah Bollom
Regional Donor and
Surrogacy Manager
Nicolette Curtis
Regional Manager
VIC and NSW
Prof Deirdre Zander-Fox
Chief Scientific
Officer
Claire Ellem
Regional Manager QLD
Tedd Fuell
Chief Governance
and Risk Officer
Hamish Hamilton
Chief Operating Officer
Malik Jainudeen
Chief Financial Officer
and Company Secretary
Sloane Karlson
General Manager Projects
Jan Lagerwij
Asia Managing Director
Peggy North
Chief People & Culture Officer
Thierry Panthier
Chief Information Officer
Rebecca Redden
Regional Manager for Ultrasound, SA/NT and Genetics
Kate Robertson
Regional Manager WA
Prof Luk Rombauts
Group Medical Director
Monique Teodoro
Regional Manager Day
Surgeries